Back To Schedule
Wednesday, June 17 • 11:30am - 12:30pm
#317 L: Evolving Trials for the Digital Age

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-20-675-L04-P; CME 1.00; IACET 1.00; RN 1.00

Interest continues to increase in harnessing technology solutions to reduce the cost of clinical trials, accelerate and diversify patient recruitment, and streamline processes perceived as burdensome or artificial by patients and site staff. With the number of marketed digital trial solutions growing rapidly, study designers and clinical operations professionals need a better understanding of the fundamental trial processes that can benefit from digital innovations. This session identifies numerous areas in clinical study operations, from study approval through close-out, with potential impact from digital innovation. It also identifies considerations for when digital enhancements may or may not be useful, as well as which elements of clinical operations may actually interfere with digital innovation.

Learning Objectives

Describe key features of traditional clinical trials where technology may reduce the burden of study conduct, as well as limits that should be considered when implementing digital trial technology; Identify assumptions in trial operations that impede technology adoption and employ change management techniques to make trials ready for digital innovation


Vernon F Schabert, III, PhD


Research Operations Best Practices for Site-Based EHR Studies
Vernon F Schabert, III, PhD

Harnessing Mobile Cloud Technology to Improve Clinical Trial Monitoring
MaryAnne Rizk, PhD

Telemedicine: Reducing Patient and Site Burden
Alison Holland

avatar for MaryAnne Rizk

MaryAnne Rizk

Senior Vice President, Digital R&D Strategy, IQVIA
Dr. Rizk has been a rising global digital technology lifescience executive for the past 20+ years, transforming the way the biopharmaceutical industry manages digital health to improve patient outcomes. Effective in building enterprise alliance programs, She has forged clinical outsourcing... Read More →
avatar for Michelle Longmire

Michelle Longmire

CEO & Co-Founder, Medable, United States
As the co-founder and Chief Executive Officer of Medable, Dr. Michelle Longmire is mission-driven to accelerate the development of new therapies for disease. A Stanford-trained physician-scientist, Dr. Longmire witnessed firsthand the critical barriers to drug development – including... Read More →
avatar for Vernon Schabert

Vernon Schabert

Consultant, Epilogix
Vernon Schabert is an internationally-recognized Real-World Evidence (RWE) strategist and scientist for the life sciences industry. Dr. Schabert has led multi-country research for nearly 25 years, in 20 global markets, with companies including IQVIA, PPD, Certara, and IBM Watson... Read More →
avatar for Alison Holland

Alison Holland

Executive General Manager, Digital and Decentralized Solutions, Medable, United States
Alison (Ali) Holland is Executive GM, Digital and Decentralized Solutions at Medable and is chartered to design and expand the end-to-end capabilities needed to partially or fully virtualize clinical studies, building on the commitment to reduce clinical trial times by 50%. Ali has... Read More →

Wednesday June 17, 2020 11:30am - 12:30pm EDT
TBD Virtual Event Horsham, PA 19044
  02: ClinTrials -ClinOps, Session